These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 17131467)
1. Insulin resistance and hepatitis C. Romero-Gómez M World J Gastroenterol; 2006 Nov; 12(44):7075-80. PubMed ID: 17131467 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis: insulin resistance and sustained virological response in hepatitis C. Eslam M; Aparcero R; Kawaguchi T; Del Campo JA; Sata M; Khattab MA; Romero-Gomez M Aliment Pharmacol Ther; 2011 Aug; 34(3):297-305. PubMed ID: 21623851 [TBL] [Abstract][Full Text] [Related]
3. Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C. Sanyal AJ Liver Int; 2011 Jan; 31 Suppl 1():23-8. PubMed ID: 21205134 [TBL] [Abstract][Full Text] [Related]
4. Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients. Dai CY; Huang JF; Hsieh MY; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL; Yu ML J Hepatol; 2009 Apr; 50(4):712-8. PubMed ID: 19231011 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and insulin resistance: steatosis, fibrosis and non-response. Romero-Gómez M Rev Esp Enferm Dig; 2006 Aug; 98(8):605-15. PubMed ID: 17048997 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1. Serfaty L; Forns X; Goeser T; Ferenci P; Nevens F; Carosi G; Drenth JP; Lonjon-Domanec I; DeMasi R; Picchio G; Beumont M; Marcellin P Gut; 2012 Oct; 61(10):1473-80. PubMed ID: 22387529 [TBL] [Abstract][Full Text] [Related]
7. DOES INSULIN RESISTANCE IMPAIR THE VIROLOGICAL RESPONSE TO PEGINTERFERON/RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS? Laurito MP; Silva GF; Cheinquer H; Sharma R; Verna E; Parise ER Arq Gastroenterol; 2018; 55(2):179-183. PubMed ID: 30043870 [TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy. Khattab MA; Abdel-fattah ME; Eslam M; Abdelaleem A; Abdelaleem RA; Shatat M; Ali A; Hamdy L; Tawfek H J Clin Gastroenterol; 2010; 44(10):707-12. PubMed ID: 20195166 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients. Khattab M; Eslam M; Sharwae MA; Shatat M; Ali A; Hamdy L Am J Gastroenterol; 2010 Sep; 105(9):1970-7. PubMed ID: 20234345 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: some issues. Wu KT; Yang JF; Chuang WL; Yu ML J Hepatol; 2010 Feb; 52(2):305; author reply 305-6. PubMed ID: 20006403 [No Abstract] [Full Text] [Related]
11. Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. Fattovich G; Baroni GS; Pasino M; Pierantonelli I; Covolo L; Ieluzzi D; Passigato N; Tonon A; Faraci MG; Guido M; Negro F Dig Liver Dis; 2012 May; 44(5):419-25. PubMed ID: 22277808 [TBL] [Abstract][Full Text] [Related]
12. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C. Jian Wu Y; Shu Chen L; Gui Qiang W Liver Int; 2006 Mar; 26(2):166-72. PubMed ID: 16448454 [TBL] [Abstract][Full Text] [Related]
13. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Conjeevaram HS; Wahed AS; Afdhal N; Howell CD; Everhart JE; Hoofnagle JH; Gastroenterology; 2011 Feb; 140(2):469-77. PubMed ID: 21070775 [TBL] [Abstract][Full Text] [Related]
14. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C. Hauser G; Awad T; Brok J; Thorlund K; Štimac D; Mabrouk M; Gluud C; Gluud LL Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005441. PubMed ID: 24585509 [TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy. Persico M; Capasso M; Persico E; Svelto M; Russo R; Spano D; Crocè L; La Mura V; Moschella F; Masutti F; Torella R; Tiribelli C; Iolascon A Hepatology; 2007 Oct; 46(4):1009-15. PubMed ID: 17668875 [TBL] [Abstract][Full Text] [Related]
16. Peginterferon and ribavirin for hepatitis C. Assy N; Embon O N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17380576 [No Abstract] [Full Text] [Related]